MEDICAL UPDATE: Rifabutin for Prevention of MAC

MEDICAL UPDATE: Rifabutin for Prevention of MAC

Being Alive; April 1992
presented by Mark Katz MD and reported by Jim Stoecker

Rifabutin has been around for some time as part of the multi-drug regimen used to treat MAC. Now the drug's manufacturer, Adria Labs, has announced a treatment IND that uses rifabutin as MAC prophylaxis. Participants must have a CD4 count less than two hundred, have no prior history of MAC, and be on no investigational drugs. For full information, call, or have your medical provider call, Adria Labs at 800.552.7228.

920401
BA920408

AEGiS is made possible through unrestricted grants from Roxane Laboratories, the National Library of Medicine, and donations from users like you. Always watch for outdated information. Always watch for outdated information. This article first appeared in 1992. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1992 - Beings Alive. Permission granted for noncommercial reproduction, provided that our address and phone number are included if more than short quotations are used. Subscription lists are kept confidential. Being Alive, 621 N. San Vicente Blvd., West Hollywood, CA 90069, Tel - 310.289.2551; FAX - 310.289.9866; Email: BeiAlive@aol.com http://www.beingalivela.org/

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1992. AEGIS.